AI-generated summary
The authors conducted an integrative review of 14 clinical trials and case reports on photobiomodulation for mental health conditions such as anxiety, depression, and seasonal affective disorder. They report potential benefits, including changes in brain activity, reduced anxiety, and antidepressant effects, along with mild and infrequent adverse events. The authors note high variability in treatment protocols.
- Studies included
- 14
- Who or what was studied
- People with mental health conditions, including anxiety, depression, and seasonal affective disorder
- Limits stated in the abstract
- The abstract notes high variability in protocols that limits reproducibility and generalizability, and calls for large randomized controlled trials to validate clinical utility.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Anxiety, Depression, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.